Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2004
09/15/2004EP1456198A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
09/15/2004EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
09/15/2004EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer
09/15/2004EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors
09/15/2004EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1455579A1 Pyrazoles-pyrimidine fungicides
09/15/2004EP1363902B1 Chemical compounds
09/15/2004EP1295878B1 Pyrazinone derivatives
09/15/2004EP1196408B1 Respiratory syncytial virus replication inhibitors
09/15/2004EP1019398B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/15/2004EP1001774B1 Use of phospholamban inhibitors for increasing coronary flow
09/15/2004EP0693072B9 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
09/15/2004CN1529884A 光记录介质 The optical recording medium
09/15/2004CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same
09/15/2004CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative
09/15/2004CN1529593A 2-pyrrolidone derivatives as prostanoid agonists
09/15/2004CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate
09/15/2004CN1166665C Arylpiperidine derivatives and use thereof
09/15/2004CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors
09/15/2004CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof
09/15/2004CN1166639C Antimalarial quinolin derivatives, its preparation and use
09/15/2004CN1166638C Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
09/15/2004CN1166636C Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
09/15/2004CN1166635C Trifuoro methylpyrrol carboxamides
09/14/2004US6790860 Pyrrolidine derivatives
09/14/2004US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents
09/14/2004US6790844 Muscle relaxants; antiserotonine agent
09/14/2004CA2264549C Spirocyclic dopamine receptor subtype ligands
09/10/2004WO2004076445A2 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
09/10/2004WO2004076444A2 Novel hydroxycoumaranone derivatives as antitumor and antimetastatic
09/10/2004WO2004076437A1 Benzopyran compounds, process for preparing the same and their use
09/10/2004WO2004076433A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076424A1 Heterocyclic kinase inhibitors
09/10/2004WO2004076421A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004WO2004075823A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004050643A3 Non-nucleoside reverse transcriptase inhibitors
09/10/2004WO2004043392B1 Mucin synthesis inhibitors
09/10/2004WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT
09/10/2004WO2004034985A3 Chemical compounds
09/10/2004WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders
09/10/2004WO2004007444A3 N-hydroxyamide derivatives possessing antibacterial activity
09/10/2004WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
09/10/2004CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004CA2516660A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/10/2004CA2516239A1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
09/09/2004US20040176617 Novel dyes
09/09/2004US20040176615 Forming calcium salt from ester
09/09/2004US20040176610 Indolone oxazolidinones and derivatives thereof
09/09/2004US20040176605 Compounds as antumor agents or immunosuppressants
09/09/2004US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
09/09/2004US20040176602 3-Cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
09/09/2004US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent
09/09/2004US20040176443 Capsaicin receptor ligands
09/09/2004US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
09/09/2004US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders
09/09/2004US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase
09/09/2004US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity
09/09/2004US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation
09/09/2004US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori
09/09/2004US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
09/09/2004US20040176355 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment
09/09/2004US20040176348 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
09/09/2004US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections
09/09/2004US20040176271 2-amino-4-aryl or heteroaryl pyridines or pyrimidines; Janus kinases (JAK)
09/09/2004US20040176248 Imaging system
09/09/2004US20040173777 Fluorescent diketopyrrolopyrrole analogues
09/09/2004DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments
09/08/2004EP1454907A1 Quninazoline and pyridopyrmidine derivatives
09/08/2004EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia
09/08/2004EP1453825A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
09/08/2004EP1453823A1 2-guanidino-4-heterocyclylquinazolines
09/08/2004EP1453811A2 Peroxisome proliferator activated receptor agonists
09/08/2004EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
09/08/2004EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist
09/08/2004EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
09/08/2004EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
09/08/2004EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453515A2 Method to treat cystic fibrosis
09/08/2004EP1453512A1 Acetylene derivatives having mglur 5 antagonistic activity
09/08/2004EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
09/08/2004EP1453492A2 Use of quinazolines to treat t-cell mediated diseases
09/08/2004EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/08/2004EP1194416B1 Halopyrimidines
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004EP1150746B1 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
09/08/2004EP1075474B1 Process for making 1,3-disubstituted-4-oxocyclic ureas
09/08/2004EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
09/08/2004EP1007523B9 Indole and 2,3-dihydroindole derivatives, their preparation and use
09/08/2004EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists
09/08/2004EP0824524B1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/08/2004EP0785782B1 Use of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity
09/08/2004EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules
09/08/2004CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes
09/08/2004CN1527829A Pyrazole derivatives as HIV reverse transcriptase inhibitors